Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)

Conditions: Multi-Drug Resistant Organism Colonization Interventions: Drug: Allogeneic Microbiota in Glycerol (9%) (AMG) Sponsors: Emory University; Centers for Disease Control and Prevention Not yet recruiting

https://clinicaltrials.gov/study/NCT06321536

Source: ClinicalTrials.gov - March 20, 2024 Category: Research Source Type: clinical trials

More News: Antimicrobial Resistance | Centers for Disease Control and Prevention (CDC) | Research